Journal of Nuclear Medicine: 58 (Supplement 2)

September 1, 2017; Volume 58,Issue Supplement 2

A

Altmann, Annette
1. You have access
  Identification of Ligands and Translation to Clinical Applications
  Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791

B

Babich, John
1. You have access
  Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
  Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
2. You have access
  Identification of Ligands and Translation to Clinical Applications
  Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Bařinka, Cyril
1. You have access
  Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
  Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
Benešová, Martina
1. You have access
  Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
  Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
2. You have access
  Therapeutic Radiometals Beyond ¹⁷⁷Lu and ⁹⁰Y: Production and Application of Promising α-Particle, β⁻-Particle, and Auger Electron Emitters
  Cristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger Schibli
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825
Boas, F. Edward
1. You have access
  Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes
  F. Edward Boas, Lisa Bodei and Constantinos T. Sofocleous
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229
Bodei, Lisa
1. You have access
  In Memoriam: Dirk J. Kwekkeboom (1958–2017)
  Lisa Bodei
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 7A;
2. You have access
  Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes
  F. Edward Boas, Lisa Bodei and Constantinos T. Sofocleous
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229
3. You have access
  Somatostatin Receptor 2–Targeting Compounds
  Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa Bodei
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015
Brouwers, Adrienne H.
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940

C

Calais, Jeremie
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Cremonesi, Marta
1. You have access
  Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
  Uta Eberlein, Marta Cremonesi and Michael Lassmann
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841

D

de Groot, Derk Jan A.
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
de Vries, Elisabeth G.E.
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940

E

Eberlein, Uta
1. You have access
  Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
  Uta Eberlein, Marta Cremonesi and Michael Lassmann
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841
Eiber, Matthias
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767

F

Fani, Melpomeni
1. You have access
  Somatostatin Receptor Antagonists for Imaging and Therapy
  Melpomeni Fani, Guillaume P. Nicolas and Damian Wild
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 61S-66S; DOI: https://doi.org/10.2967/jnumed.116.186783
Fehrmann, Rudolf S.N.
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
Fendler, Wolfgang P.
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767

G

Giesel, Frederik L.
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Giesen, Danique
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940

H

Haberkorn, Uwe
1. You have access
  Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
  Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
2. You have access
  Identification of Ligands and Translation to Clinical Applications
  Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Herold-Mende, Christel
1. You have access
  Identification of Ligands and Translation to Clinical Applications
  Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Herrmann, Ken
1. You have access
  CXCR4 Ligands: The Next Big Hit?
  Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen Wester
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
2. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
3. You have access
  Theranostic Concepts: More Than Just a Fashion Trend—Introduction and Overview
  Ken Herrmann, Steven M. Larson and Wolfgang A. Weber
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.117.199570
Hetkamp, Philipp
1. You have access
  Iodine Symporter Targeting with ¹²⁴I/¹³¹I Theranostics
  James Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter Jentzen
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866
Hofman, Michael S.
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767

J

Jalving, Mathilde
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
Janssen, Marcel
1. You have access
  Iodine Symporter Targeting with ¹²⁴I/¹³¹I Theranostics
  James Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter Jentzen
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866
Jentzen, Walter
1. You have access
  Iodine Symporter Targeting with ¹²⁴I/¹³¹I Theranostics
  James Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter Jentzen
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866

K

Kok, Iris C.
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
Kopka, Klaus
1. You have access
  Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
  Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
2. You have access
  Identification of Ligands and Translation to Clinical Applications
  Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Kratowchil, Clemens
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Krenning, Eric P.
1. You have access
  Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine
  Rachel Levine and Eric P. Krenning
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 3S-9S; DOI: https://doi.org/10.2967/jnumed.116.186502
Kwekkeboom, Dik J.
1. You have access
  Somatostatin Receptor 2–Targeting Compounds
  Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa Bodei
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015

L

Lapa, Constantin
1. You have access
  CXCR4 Ligands: The Next Big Hit?
  Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen Wester
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
Larson, Steven M.
1. You have access
  Theranostic Concepts: More Than Just a Fashion Trend—Introduction and Overview
  Ken Herrmann, Steven M. Larson and Wolfgang A. Weber
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.117.199570
Lassmann, Michael
1. You have access
  Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
  Uta Eberlein, Marta Cremonesi and Michael Lassmann
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841
Levine, Rachel
1. You have access
  Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine
  Rachel Levine and Eric P. Krenning
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 3S-9S; DOI: https://doi.org/10.2967/jnumed.116.186502
Lub-de Hooge, Marjolijn N.
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940

M

Maecke, Helmut R.
1. You have access
  Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand Applications
  Jean Claude Reubi and Helmut R. Maecke
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 10S-16S; DOI: https://doi.org/10.2967/jnumed.116.186882
Maurer, Tobias
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Mier, Walter
1. You have access
  Identification of Ligands and Translation to Clinical Applications
  Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Modak, Shakeel
1. You have access
  Norepinephrine Transporter as a Target for Imaging and Therapy
  Neeta Pandit-Taskar and Shakeel Modak
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 39S-53S; DOI: https://doi.org/10.2967/jnumed.116.186833
Moek, Kirsten L.
1. You have access
  Theranostics Using Antibodies and Antibody-Related Therapeutics
  Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
Müller, Cristina
1. You have access
  Therapeutic Radiometals Beyond ¹⁷⁷Lu and ⁹⁰Y: Production and Application of Promising α-Particle, β⁻-Particle, and Auger Electron Emitters
  Cristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger Schibli
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825

N

Nagarajah, James
1. You have access
  Iodine Symporter Targeting with ¹²⁴I/¹³¹I Theranostics
  James Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter Jentzen
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866
Nicolas, Guillaume P.
1. You have access
  Somatostatin Receptor Antagonists for Imaging and Therapy
  Melpomeni Fani, Guillaume P. Nicolas and Damian Wild
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 61S-66S; DOI: https://doi.org/10.2967/jnumed.116.186783

P

Pandit-Taskar, Neeta
1. You have access
  Norepinephrine Transporter as a Target for Imaging and Therapy
  Neeta Pandit-Taskar and Shakeel Modak
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 39S-53S; DOI: https://doi.org/10.2967/jnumed.116.186833

R

Reubi, Jean Claude
1. You have access
  Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand Applications
  Jean Claude Reubi and Helmut R. Maecke
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 10S-16S; DOI: https://doi.org/10.2967/jnumed.116.186882
Rowe, Steven P.
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767

S

Schibli, Roger
1. You have access
  Therapeutic Radiometals Beyond ¹⁷⁷Lu and ⁹⁰Y: Production and Application of Promising α-Particle, β⁻-Particle, and Auger Electron Emitters
  Cristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger Schibli
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825
Schwarzenboeck, Sarah M.
1. You have access
  Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
  Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Smit Duijzentkunst, Daan A.
1. You have access
  Somatostatin Receptor 2–Targeting Compounds
  Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa Bodei
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015
Sofocleous, Constantinos T.
1. You have access
  Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes
  F. Edward Boas, Lisa Bodei and Constantinos T. Sofocleous
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229

V

van der Meulen, Nicholas P.
1. You have access
  Therapeutic Radiometals Beyond ¹⁷⁷Lu and ⁹⁰Y: Production and Application of Promising α-Particle, β⁻-Particle, and Auger Electron Emitters
  Cristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger Schibli
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825

W

Walenkamp, Annemiek M.E.
1. You have access
  CXCR4 Ligands: The Next Big Hit?
  Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen Wester
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
Weber, Wolfgang A.
1. You have access
  Theranostic Concepts: More Than Just a Fashion Trend—Introduction and Overview
  Ken Herrmann, Steven M. Larson and Wolfgang A. Weber
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.117.199570
Wester, Hans-Jürgen
1. You have access
  CXCR4 Ligands: The Next Big Hit?
  Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen Wester
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
Wild, Damian
1. You have access
  Somatostatin Receptor Antagonists for Imaging and Therapy
  Melpomeni Fani, Guillaume P. Nicolas and Damian Wild
  
  Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 61S-66S; DOI: https://doi.org/10.2967/jnumed.116.186783

Main menu

User menu

Search

Table of Contents

A

Altmann, Annette

B

Babich, John

Bařinka, Cyril

Benešová, Martina

Boas, F. Edward

Bodei, Lisa

Brouwers, Adrienne H.

C

Calais, Jeremie

Cremonesi, Marta

D

de Groot, Derk Jan A.

de Vries, Elisabeth G.E.

E

Eberlein, Uta

Eiber, Matthias

F

Fani, Melpomeni

Fehrmann, Rudolf S.N.

Fendler, Wolfgang P.

G

Giesel, Frederik L.

Giesen, Danique

H

Haberkorn, Uwe

Herold-Mende, Christel

Herrmann, Ken

Hetkamp, Philipp

Hofman, Michael S.

J

Jalving, Mathilde

Janssen, Marcel

Jentzen, Walter

K

Kok, Iris C.

Kopka, Klaus

Kratowchil, Clemens

Krenning, Eric P.

Kwekkeboom, Dik J.

L

Lapa, Constantin

Larson, Steven M.

Lassmann, Michael

Levine, Rachel

Lub-de Hooge, Marjolijn N.

M

Maecke, Helmut R.

Maurer, Tobias

Mier, Walter

Modak, Shakeel

Moek, Kirsten L.

Müller, Cristina

N

Nagarajah, James

Nicolas, Guillaume P.

P

Pandit-Taskar, Neeta

R

Reubi, Jean Claude

Rowe, Steven P.

S

Schibli, Roger

Schwarzenboeck, Sarah M.

Smit Duijzentkunst, Daan A.

Sofocleous, Constantinos T.

V

van der Meulen, Nicholas P.

W

Walenkamp, Annemiek M.E.

Weber, Wolfgang A.

Wester, Hans-Jürgen

Wild, Damian

In this issue